Patent · US Active

Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C

US9987277B2 · kind B2 · utility

0Cited by

5References

27Claims

0Family size

Assignee

Janssen Sciences Ireland UC · IE

Inventors

Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Oliver Lenz · Sint-Katelijne-Waver, BE
Tse-I Lin · Mechelen, BE
Kenneth Alan Simmen · Tervuren, BE

Key dates

Filing date	Oct 4, 2007
Grant date	Jun 5, 2018
Priority date	—
Expiry date	Aug 11, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of carboxamide 4-[(4-pyridyl)amino]-pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.